Our data demonstrated that tetrac enhanced the antitumor effect of heteronemin in HT-29 cells (KRAS WT CRC) and HCT-116 cells (KRAS MT CRC; Figure 1A,B). This evidence concerns the gene KRAS and colorectal carcinoma.